MedPath

KYOWA KIRIN CO., LTD.

KYOWA KIRIN CO., LTD. logo
🇯🇵Japan
Ownership
Public, Subsidiary
Established
1949-07-01
Employees
5.9K
Market Cap
-
Website
http://www.kyowa-kirin.co.jp

Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL)

Phase 2
Active, not recruiting
Conditions
Indolent B-cell Non-Hodgkin's Lymphoma
Interventions
First Posted Date
2020-08-31
Last Posted Date
2024-07-17
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
61
Registration Number
NCT04533581
Locations
🇯🇵

National Hospital Organization Nagoya Medical Center, Nagoya, Aichi, Japan

🇯🇵

National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan

🇯🇵

Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan

and more 27 locations

A Study of KHK4827 in Patients With Systemic Sclerosis

Phase 1
Active, not recruiting
Conditions
Systemic Sclerosis
Interventions
First Posted Date
2020-04-29
Last Posted Date
2024-12-24
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
8
Registration Number
NCT04368403
Locations
🇯🇵

The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan

A Through QT/QTc Study of KW-6356

Phase 1
Completed
Conditions
Parkinson's Disease
Interventions
First Posted Date
2020-04-13
Last Posted Date
2020-09-18
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
128
Registration Number
NCT04342273
Locations
🇯🇵

Medical Co. LTA Sumida Hospital, Sumida-ku, Tokyo, Japan

🇯🇵

Medical Co. LTA Fukuoka Mirai Hospital Clinical Research Center, Fukuoka, Japan

A Study of KRN23 in Adult and Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia

Phase 3
Completed
Conditions
XLH
Interventions
First Posted Date
2020-03-13
Last Posted Date
2022-09-06
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
27
Registration Number
NCT04308096
Locations
🇯🇵

National University Corporation Osaka University, Suita, Osaka, Japan

🇯🇵

The University of Tokyo Hospital, Bunkyō-Ku, Tokyo, Japan

🇯🇵

Hokkaido University Hospital, Sapporo, Hokkaido, Japan

and more 7 locations

Pharmacokinetic Study of KHK7580 in Healthy Adult Volunteers

Phase 1
Completed
Conditions
Healthy Volunteer
Interventions
Drug: 1mg KHK7580
Drug: 3mg KHK7580
Drug: 6mg KHK7580
Drug: 12mg KHK7580
Drug: 6mg KHK7580 for 8days
First Posted Date
2019-12-20
Last Posted Date
2021-09-08
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
42
Registration Number
NCT04206657
Locations
🇨🇳

Beijing hospital, Beijing, Beijing, China

A Phase 4 Clinical Study of Brodalumab

Phase 4
Completed
Conditions
Psoriatic Erythroderma
Psoriasis Vulgaris
Pustular; Psoriasis, Palmaris Et Plantaris
Psoriatic Arthritis
Interventions
First Posted Date
2019-12-03
Last Posted Date
2019-12-09
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
138
Registration Number
NCT04183881
Locations
🇯🇵

The Jikei University Scoole of Medicine, Tokyo, Japan

KW-3357 Study in Patients With Early Onset Severe Preeclampsia

Phase 3
Completed
Conditions
Preeclampsia
Interventions
Drug: physiological saline
First Posted Date
2019-12-02
Last Posted Date
2023-11-15
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
181
Registration Number
NCT04182373
Locations
🇯🇵

National Center for Child Health and Development, Setagaya, Tokyo, Japan

🇯🇵

Aiiku Hospital, Minato, Tokyo, Japan

🇯🇵

Okinawa prefectural Chubu Hospital, Uruma, Okinawa, Japan

and more 60 locations

Study of AMG531 (Romiplostim) in Patients With Aplastic Anemia

Phase 2
Completed
Conditions
Aplastic Anemia
Interventions
First Posted Date
2019-09-19
Last Posted Date
2022-05-26
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
24
Registration Number
NCT04095936
Locations
🇯🇵

NTT Medical center Tokyo, Shinagawa, Tokyo, Japan

A Drug Interaction Study of KW-6356 and Clarithromycin or Rifampicin

Phase 1
Completed
Conditions
Parkinson's Disease
Interventions
First Posted Date
2019-08-28
Last Posted Date
2019-11-29
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
20
Registration Number
NCT04070495
Locations
🇯🇵

Medical Co. LTA Sumida Hospital, Sumida-ku, Tokyo, Japan

A Study of KHK4827 in Subjects With Palmoplantar Pustulosis

Phase 3
Completed
Conditions
Palmoplantar Pustulosis
Interventions
Drug: Placebo
First Posted Date
2019-08-19
Last Posted Date
2023-02-14
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
126
Registration Number
NCT04061252
Locations
🇯🇵

Takagi Dermatology clinic, Obihiro, Hokkaido, Japan

🇯🇵

Sapporo Dermatology clinic, Sapporo, Hokkaido, Japan

© Copyright 2025. All Rights Reserved by MedPath